Viewing Study NCT03581292


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2026-01-09 @ 1:25 PM
Study NCT ID: NCT03581292
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-13
First Post: 2018-07-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
Sponsor: National Cancer Institute (NCI)
Organization: